Developing public policy for genetic diagnostic services

该项目是一项概念性分析，旨在描述将经验保健服务数据转化为公共政策所需的规范性假设。对威斯康星州囊性纤维化新生儿筛查公共政策制定过程的分析已经完成。该分析包括几个关键发现。首先，如果常规项目显著改变了筛查方法，就不能假设在研究阶段发现的任何益处。其次，这些益处必须在CF专利的其他潜在放弃益处的背景下考虑。第三，这些益处必须在其他儿童的其他潜在放弃益处的背景下考虑。最后，这些好处必须与假阳性家庭的潜在危害相对照。

This project is a conceptual analysis to describe the normative assumptions necessary to translate empirical health services data into public policy. An analysis of this process for the development of public policy for cystic fibrosis newborn screening in Wisconsin has been completed. This analysis included several key findings. First, any benefits found during the research phase can not be assumed if a routine program dramatically alters the screening approach. Second, these benefits must be considered within the context of other potentially forgone benefits to patents with CF. Third, the benefits must be considered within the context of other potentially forgone benefits to other children. Finally, these benefits must be considered in contrast to potential harms to false positive families.